Core Insights - The article highlights the progress in the management and quality safety regulation of traditional Chinese medicine (TCM) as of the end of 2025, with a focus on risk prevention and monitoring in the industry [1] Group 1: Industry Overview - By the end of 2025, a total of 475 TCM production bases have been established, covering nearly 1.24 million acres, which can supply 101 types of TCM materials to 215 TCM production enterprises for the production of 275 varieties [1] - The National Medical Products Administration (NMPA) is emphasizing risk warning in TCM, urging production enterprises to enhance monitoring and take timely measures to control risks and eliminate hidden dangers [1] Group 2: Regulatory Developments - The NMPA has improved the safety information in TCM product instructions and issued requirements for the submission of safety content changes in drug instructions for already marketed TCM [1] - Five announcements have been released, involving 666 approved numbers, and 21 related supplementary applications have been completed [1]
国家药监局：2025年475个中药材生产基地通过检查
Yang Shi Xin Wen·2026-02-27 01:22